February 20-22, 2020 – GreenMark exhibited at the Chicago Dental Society Midwinter Meeting at the McCormick Center, Feb. 20-22, 2020. What follows is a brief introduction and then a pictorial summary of the first major exhibit and “soft launch” event for the team introducing GreenMark’s technology platform and first product LumiCare™ Caries Diagnostic Rinse, to become […]
Read MoreDental Economics, December 9, 2019 – In 1971, John Lennon famously asked us to imagine a different world. His words still resonate today, and we can apply them to our own dental world. Can you imagine people living without secondary caries? Can you imagine if we could treat white spots noninvasively? We don’t have to imagine anymore. […]
Read More
Fall 2019 – GreenMark Biomedical Inc. is a Michigan-based, minimally invasive healthcare company that was founded in 2016 by Dr. Steven Bloembergen with a mission to “enable dentists to preserve teeth through early diagnosis and treatment”. Dr. Bloembergen is a co-founder of EcoSynthetix Inc., a global bio-based nanoparticle manufacturer. In partnership with collaborators at the University […]
Read MoreSeptember 30, 2019 – Using nanotechnology, GreenMark Biomedical is developing a non-invasive approach to diagnosing and treating active, incipient carious lesions. The idea of nanodentistry may still seem a little like pure science fiction or a distant vision. In fact, products based on “small scale” targeted technology for diagnosing, treating and preventing caries may well be […]
Read MoreEast Lansing and Ann Arbor, MI – March 19, 2019 – GreenMark Biomedical Inc. today announced it secured $670K equity funding completing a $1.2M Series Seed Preferred Stock round to further develop and commercialize its patented nanoparticle-based dental technology. The University of Michigan’s MINTS program, Invest Michigan and Red Cedar Ventures investments follow earlier funding from […]
Read MoreAnn Arbor, MI – May 14, 2018 – GreenMark Biomedical Inc. today announced that it has been selected to present at the 37th annual Michigan Growth Capital Symposium (MGCS). GreenMark, a Delaware corporation with facilities in Michigan will be presenting to investors in attendance, including more than 100 top venture capital firms.
Read MoreApril 4, 2018 – GreenMark Biomedical Inc. today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant in the amount of US $228,883 from the National Institutes of Health (NIH). The grant will fund a collaborative project between GreenMark and the University of Michigan (U-M).
Read More